Table 1.
Article | Study design and duration | Sample size | Mean age (years) | Population | Monitored parameters | Primary and secondary endpoints | Results |
---|---|---|---|---|---|---|---|
Chaudhry [30] Chaudhry [28••] Tele-HF USA |
RCT, multicenter (2006–2009) 24 mon, 6 month follow-up |
N = 1653 (IG: 826, CG: 827) | IG: 61 CG: 61 |
Patients with an HF hospitalization with previous month | IG: telephone-based interactive voice response that collected daily information about symptoms and weight CG: usual care |
Primary: death/readmission within 180 days, Secondary: hospitalization or death, LOS, number of hospitalizations |
No differences in primary or secondary endpoints |
Koehler [31] Germany |
RCT, multicenter, 24-month follow-up |
N = 710 (IG: 354, CG: 356) | IG: 67 CG: 67 |
Stable chronic HF patients | IG: remote monitoring of ECG, blood pressure, body weight CG: usual care |
Primary: CV mortality Secondary: composite (CV mortality/HF admission), HF-admissions, LOS, NYHA class, QOL and depression |
Improved physical function in IG, no difference between groups in all-cause mortality, CV mortality, HF-admissions, LOS, NYHA class or composite (CV mortality/HF admission) |
Ong [29••] BEAT-HF USA |
RCT (2011–2013) 6-month follow-up |
N = 1437 IG: 715 CG: 722 |
IG: 73 CG: 74 |
Hospitalized patients with HF | IG: 1) predischarge HF education, 2) telephone coaching, and 3) home telemonitoring of weight, blood pressure, heart rate and symptoms CG: usual care |
Primary: All-cause readmission within 180 days Secondary: All-cause readmission within 30 days, All-cause mortality, QOL |
No differences in All-cause 180- or 30-day readmission, 180-day mortality, Improved QOL at 180 days in intervention group |
Piotrowicz [32], Poland |
RCT, single center 8 weeks follow-up |
N = 152 (IG: 77, CG: 75) | IG: 56, CG: 61 | Hospitalized patients with HF with NYHA class II or III | IG: home-based remote monitored cardiac rehab; patient edu, psych support CG: standard cardiac rehab, patient edu, psych support |
Primary: NYHA class, QOL, peak VO2, 6 MWT | Greater improvement in NYHA class in IG, Greater improvement in 6 MWT in CG, No difference between groups in exercise duration, peak VO2 and QOL |
Scherr et al. [33] Austria |
RCT, 6 mon follow-up |
N = 120 (IG: 66, CG: 54) | IG: 66, CG: 67 | Heart failure patient with acute worsening and hospital admission lasting > 24 h | IG: Remote automated monitoring of BP, body weight, pharmacological treatment CG: pharmacological treatment |
Primary: hospitalization for worsening HF or death from cardiovascular cause Secondary: LOS, NYHA class, LVEF, Composite (CV mortality/HF admission) |
Shorter LOS in IG, median improved in NYHA from III to II in IG group only, no difference between groups in other outcomes |
Seto et al. [34] Canada |
RCT, single center, 6 mon follow-up |
N = 100 (IG: 50, CG: 50) | IG: 55, CG: 52 | Ambulatory patients with heart failure | IG: remote monitoring of ECG, blood pressure, body weight; standard care CG: standard care |
Primary: BNP, self-care, QOL Secondary: number of ER visits, LVEF, NYHA class, medication prescriptions, blood test results |
No difference between groups except for overall QOL |
Abbreviations: BNP brain natriuretic peptide, CG control group, CV cardiovascular, ECG electrocardiogram, ER emergency room, HF heart failure, IG intervention group, LOS length of stay, LVEF left ventricular ejection fraction, NYHA New York Heart Association functional class, peak VO2 peak oxygen consumption, QOL quality of life, RCT randomized controlled trial, 6 MWT 6-min walk test